Ansaldi N, Tavassoli K, Faussone D, Forni M, Oderda G
Istituto di Discipline Pediatriche, I Cattedra di Puericultura, Università di Torino, Italia.
Pediatr Med Chir. 1988 Jan-Feb;10(1):3-6.
In the last 18 years we have followed 330 children with Coeliac Disease (CD), diagnosed according to the ESPGAN criteria (with 3 jejunal biopsies: during the acute phase, after a gluten-free diet and after a gluten challenge). One to fifteen years after the diagnosis, 61 of them asked to be exposed to a second gluten challenge to see if their intolerance was persistent. Ten percent of them had already started the challenge by themselves, the others were on Gluten Free Diet (GFD). To all 61 serial clinical controls, one-hour-blood-xylose absorption test every three months and a jejunal biopsy was suggested. The jejunal biopsy was performed when symptoms recurred, or when xylose-test showed an impaired absorption, or after 2 years. If the first jejunal biopsy showed a villous atrophy the GFD was restarted, while if a normal mucosa was found the gluten challenge was continued and the jejunal biopsy repeated every year. 52 children (85%) showed a villous atrophy after 1.5 to 72 months. 6 (10%) did not show a clinical or histological relapse, 2 refused the jejunal biopsy because symptomless, and 1 had to restart the GFD because she developed a dermatitis herpetiformis. One-hour-blood-xylose test was performed in 29 children and 20 (69%) showed a low absorbtion, the majority of them in the first year of challenge, and the remaining refused it. 36 of the relapsed children presented with mild clinical symptoms while 16 were symptomless.(ABSTRACT TRUNCATED AT 250 WORDS)
在过去18年里,我们对330名乳糜泻(CD)患儿进行了跟踪观察,这些患儿均根据欧洲儿科胃肠病学、肝病学和营养学会(ESPGAN)标准确诊(通过3次空肠活检:急性期、无麸质饮食后和麸质激发试验后)。确诊后1至15年,其中61名患儿要求接受第二次麸质激发试验,以查看其不耐受情况是否持续存在。他们中有10%已自行开始激发试验,其余患儿则采用无麸质饮食(GFD)。建议对所有61名患儿进行连续临床对照,每三个月进行一次一小时血液木糖吸收试验,并进行空肠活检。当症状复发、木糖试验显示吸收受损或2年后进行空肠活检。如果首次空肠活检显示绒毛萎缩,则重新开始GFD,而如果发现黏膜正常,则继续进行麸质激发试验,并每年重复进行空肠活检。52名儿童(85%)在1.5至72个月后出现绒毛萎缩。6名(10%)未出现临床或组织学复发,2名因无症状拒绝空肠活检,1名因出现疱疹样皮炎而不得不重新开始GFD。对29名儿童进行了一小时血液木糖试验,20名(69%)显示吸收较低,其中大多数在激发试验的第一年,其余拒绝试验。36名复发儿童出现轻度临床症状,16名无症状。(摘要截断于250字)